Blood pressures and cardiovascular homeostasis in mice having reduced or absent angiotensin-converting enzyme gene function

Hypertension

Volumn 30, Issue 1, 1997, Pages 128-133

  Tian, Baohong ^a   Meng, Qing Cheng ^a   Chen, Yiu Fai ^a   Krege, John H ^b   Smithies, Oliver ^b   Oparil, Suzanne ^a,c  

^a Center for Palliative Care   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Angiotensin I; Angiotensin II; Bradykinin; Gene targeting; Renin

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RESPONSE; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC POLYMORPHISM; HYPERTENSION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030750735     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.1.128     Document Type: Article

References (38)

1. Oparil S, Haber E. The renin-angiotensin system. N Engl J Med. 1974;291:389-401, 446-457.
2. Fish AF. Angiotensin converting enzyme inhibitors: inhibition of growth, a novel mechanism of action. J Cardiovasc Nurs. 1994;8: 57-71.
3. Greenwald L, Becker RC, Mass W. Expanding the paradigm of the renin angiotensin system and angiotensin-converting enzyme inhibitors. Am Heart J. 1994;128:997-1009.
4. Johnston CI. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension. 1994; 23:258-268.
5. Oparil S, Meng QC, Sun S, Chen YF, Dell'Italia LJ. Tissue angiotensin converting enzyme. In: Catravas JD, Callow AD, Ryan US, eds. Vascular Endothelium: Responses to Injury. New York, NY: Plenum Press; 1996:205-239.
6. Bernstein KE, Martin BM, Bernstein EA, Linton J, Striker L, Striker G. The isolation of angiotensin converting enzyme cDNA. J Biol Chem. 1988;263:11021-11024.
7. Bernstein KE, Martin BM, Edwards AS, Bernstein EA. Mouse angiotensin-converting enzyme is a protein composed of two homologous domains. J Biol Chem. 1989;264:11945-11951.
8. Howard TE, Shai S-Y, Langford KG, Martin BM, Bernstein KE. Transcription of testicular angiotensin-converting enzyme (ACE) is initiated within the 12th intron of the somatic ACE gene. Mol Cell Biol. 1990;10:4294-4302.
9. Krege JH, John SWM, Langenbach LL, Hodgin JB, Hagaman JR, Bachman ES, Jennette JC, O'Brien DA, Smithies O. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature. 1995;375:146-148.
10. Meng QC, Balcells E, Dell'Italia L, Durand J, Oparil S. Sensitive method for quantitation of angiotensin converting enzyme (ACE) activity in tissue. Biochem Pharmacol. 1995;50:1445-1450.
11. Cushman DW, Cheung HS. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol. 1971;20:1637-1648.
12. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
13. Burnham CE, Hawelu-Johnson DL, Frank BM, Lynch KR. Molecular cloning of rat renin cDNA and its gene. Proc Natl Acad Sci U S A. 1987;84:5605-5609.
14. Lynch KR, Simnad ET, Ben-Ari ET, Garrison JC. Localization of preangiotensinogen messenger RNA sequences in the rat brain. Hypertension. 1986;8:540-543.
15. Elton TS, Stephan CC, Taylor GR, Kimball MG, Martin MM, Durand JN, Oparil S. Isolation of two distinct type I angiotensin II receptor genes. Biochem Biophys Res Commun. 1992;184: 1067-1073.
16. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, Smithies O. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A. 1995;92:2735-2739.
17. Tanimoto K, Sugiyama F, Goto Y, Ishida J, Takimoto E, Yagami K-I, Fukamizu A, Murakami K. Angiotensinogen-deficient mice with hypotension. J Biol Chem. 1994;289:31334-31337.
18. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM. Regulation of blood pressure by the type IA angiotensin II receptor gene. Proc Natl Acad Sci U S A. 1995;92: 3521-3525.
19. Sugaya T, Nishimatsu S-I, Tanimoto K, Takimoto E, Yamagishi T, Imamura K, Goto S, Imaizumi K, Hisada Y, Otsuka A, Uchida H, Sugiura M, Fukuta K, Fukamizu A, Murakami K. Angiotensin II type 1a receptor-deficient mice with hypotension and hyper-reninemia. J Biol Chem. 1995;270:18719-18722.
20. Duru K, Farrow S, Wang JM, Lockette W, Kurtz T. Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am J Hypertens. 1994;7:759-762.
21. Morise T, Takeuchi Y, Takeda R. Angiotensin-converting enzyme polymorphism and essential hypertension. Lancet. 1994;343:125.
22. Barley J, Blackwood A, Miller M, Markandu ND, Carter ND, Jeffrey S, Cappuccio FP, MacGregor GA, Sagnella GA. Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens. 1996;10:31-35.
23. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, Foy CJW, Watt GCM. The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension. 1993;21:455-460.
24. Higashimori K, Zhao Y, Higaki J, Kamitani A, Katsuya T, Nakura J, Mike T, Mikami H, Ogihara T. Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Commun. 1993;191:399-404.
25. Schmidt S, van Hooft IM, Grobbee DE, Ganten D, Ritz E. Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. J Hypertens. 1993;11:345-348.
26. Vassilikioti S, Doumas M, Doumas S, Peptidis K, Karagiannis A, Balaska K, Vyzantiadis A, Zamboulis C. Angiotensin converting enzyme gene polymorphism is not related to essential hypertension in a Greek population. Am J Hypertens. 1996;9:700-702.
27. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Cambou JP, Luc G, Rakotovao R, Ducimetiere P, Soubrier F, Alhenc-Gelas F. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. 1994;90:669-676.
28. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
29. Mattu RK, Needham EW, Galton DJ, Frangos E, Clark AJ, Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation. 1995;91:270-274.
30. Gardemann A, Weiss T, Schwartz O, Eberbach A, Katz N, Hehrlein FW, Tillmanns H, Waas W, Haberbosch W. Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients. Circulation. 1995;92:2796-2799.
31. Ludwig E, Corneli PS, Anderson JL, Marshall HW, Lalouel JM, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation. 1995;91:2120-2124.
32. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirer O, Danilov S, Boelskifte S, Borch-Johnsen K, Parving H-H. Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia. 1995;38: 798-803.
33. Nakauchi Y, Suehiro T, Yamamoto M, Yasuoka N, Arii K, Kumon Y, Hamashige N, Hashimoto K. Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor gene polymorphisms as risk factors for coronary heart disease. Atherosclerosis. 1996;125:161-169.
34. Winkelmann BR, Nauck M, Klein B, Russ AP, Bohm BO, Siekmeier R, Ihnken K, Verho M, Gross W, Marz W. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease. Ann Intern Med. 1996;125:19-25.
35. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, Miyakawa T, Iwasaki R, Hiramori K. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation. 1994;90:2199-2202.
36. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet. 1992;1:72-75.
37. Zee RY, Lou YK, Griffiths LR, Morris BJ. Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun. 1992; 184:9-15.
38. Morris BJ, Zee RY. Dipeptidyl carboxypeptidase-1 gene polymorphism paradox in hypertension explained by 'deletion depletion'. J Hypertens. 1996;12:1199-1200.